No. All major GLP-1 telehealth providers, Henry Meds, Mochi Health, and Ro, accept cash-pay patients. Henry Meds and Mochi use compounded semaglutide, which doesn’t require insurance. Ro can work with insurance but also accepts self-pay.

Most providers respond within 24–48 hours after you complete your intake form and medical questionnaire. Henry Meds and Mochi Health are typically fastest. After clinical approval, your first shipment usually arrives within 5–7 business days.

Most telehealth providers require a BMI of 30+ (obese), or BMI 27+ with a weight-related condition like hypertension or type 2 diabetes. These thresholds align with FDA approval criteria for semaglutide and tirzepatide.

Compounded semaglutide is prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and prescribed by licensed clinicians. It is not FDA-approved as a finished drug product, which is the meaningful distinction. Compounders describe it as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms (semaglutide sodium or acetate) it considers different active ingredients from the approved drug. The shortage-era compounding pathway ended after the FDA declared the semaglutide shortage resolved on February 21, 2025, so compounding now proceeds under the ordinary rules for individual patients. Discuss the nuances with your prescribing provider.

Clinical trials show semaglutide (Wegovy) produces an average of ~15% body weight loss over 68 weeks. Tirzepatide (Zepbound) showed up to 22% in trials. Individual results vary significantly based on diet, adherence, dosage, and metabolism.

The lowest verified all-in price we track is $69/mo with compounded medication included, shared by 2 programs: Embody and Yucca Health (latest price check November 10, 2026). Each reaches that figure on a different term, so the cheapest program for you depends on which condition you can accept. See our full breakdown in Cheapest GLP-1 Programs Online 2026.